Characterization of the IPEC-J2 MDR1 (iP-gp) cell line as a tool for identification of P-gp substrates
- PMID: 29146563
- DOI: 10.1016/j.ejps.2017.11.007
Characterization of the IPEC-J2 MDR1 (iP-gp) cell line as a tool for identification of P-gp substrates
Abstract
Recently, we transfected the porcine intestinal cell line IPEC-J2, with human P-glycoprotein (P-gp, ABCB1). The resulting cell line, iP-gp, has a high expression of functional human P-gp in the apical membrane, and a low expression of nonhuman ATP-binding cassette (ABC) transporters. The aim of the present work was to investigate the usability of iP-gp cell line for determining transepithelial transport kinetics of the prototypical P-gp substrates digoxin and rhodamine 123. The cell line generated tight monolayers after 16days of culture, reflected by high transepithelial electrical resistance values (TEER>15,000Ω·cm2), immunocytochemistry and low fluxes of the paracellular flux marker [14C]-mannitol. Monolayer integrity was not affected the common solvents dimethyl sulfoxide (DMSO), methanol and ethanol in concentrations up to 2% (v/v). Transepithelial fluxes of [3H]-labeled digoxin and rhodamine 123 were measured at varying donor concentrations, and kinetic parameters were estimated. Km and Vmax of P-gp mediated basolateral-to-apical (B-A) flux of rhodamine 123 were estimated to 332±124μM and 111±16pmol·cm-2·min-1 (n=3, total N=6), respectively. Vmax and Km of digoxin B-A flux could not be estimated due to the low aqueous solubility of digoxin. The half maximal inhibitory concentrations (IC50) of the selective P-gp inhibitor, zosuquidar (LY-335979), were estimated to 0.05±0.01μM (n=3, total N=6) and 0.04±0.01μM (n=3, total N=6) in transport experiments with digoxin and rhodamine 123 as substrates, respectively. Bidirectional fluxes of digoxin and rhodamine 123 were measured in transfected Madin Darby canine kidney cells (MDCK II MDR1) and compared with the fluxes obtained with the iP-gp cell monolayers. Efflux ratios were highest in the iP-gp cells, due to a tighter paracellular pathway. In conclusion, both digoxin and rhodamine 123 could be used to obtain IC50 values of inhibition, Ki values were only possible to obtain using rhodamine 123. The observed tightness, robustness towards solvents and the high efflux ratios confirmed that the iP-gp cell line may serve as a useful screening tool for investigations of substrate-P-gp interactions and modulation of P-gp function.
Keywords: ABCB1; Digoxin; Efflux ratio; MDR1-P-gp inhibitor; Monolayer; P-glycoprotein; Rhodamine 123; Zosuquidar.
Copyright © 2017 Elsevier B.V. All rights reserved.
Similar articles
-
IPEC-J2 MDR1, a Novel High-Resistance Cell Line with Functional Expression of Human P-glycoprotein (ABCB1) for Drug Screening Studies.Mol Pharm. 2016 Feb 1;13(2):640-52. doi: 10.1021/acs.molpharmaceut.5b00874. Epub 2016 Jan 5. Mol Pharm. 2016. PMID: 26651362
-
Bidirectional transport of rhodamine 123 and Hoechst 33342, fluorescence probes of the binding sites on P-glycoprotein, across MDCK-MDR1 cell monolayers.J Pharm Sci. 2004 May;93(5):1185-94. doi: 10.1002/jps.20046. J Pharm Sci. 2004. PMID: 15067695
-
Screening novel CNS drug candidates for P-glycoprotein interactions using the cell line iP-gp: In vitro efflux ratios from iP-gp and MDCK-MDR1 monolayers compared to brain distribution data from mice.Eur J Pharm Biopharm. 2021 Dec;169:211-219. doi: 10.1016/j.ejpb.2021.10.006. Epub 2021 Oct 28. Eur J Pharm Biopharm. 2021. PMID: 34756975
-
11C-Labeled rhodamine-123.2012 Nov 19 [updated 2012 Dec 27]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2012 Nov 19 [updated 2012 Dec 27]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 23285492 Free Books & Documents. Review.
-
A Critical View on In Vitro Analysis of P-glycoprotein (P-gp) Transport Kinetics.J Pharm Sci. 2017 Sep;106(9):2257-2264. doi: 10.1016/j.xphs.2017.04.022. Epub 2017 Apr 21. J Pharm Sci. 2017. PMID: 28438535 Review.
Cited by
-
Data demonstrating the challenges of determining the kinetic parameters of P-gp mediated transport of low-water soluble substrates.Data Brief. 2017 Dec 6;16:655-659. doi: 10.1016/j.dib.2017.11.092. eCollection 2018 Feb. Data Brief. 2017. PMID: 29541662 Free PMC article.
-
Oral etoposide and zosuquidar bioavailability in rats: Effect of co-administration and in vitro-in vivo correlation of P-glycoprotein inhibition.Int J Pharm X. 2021 Jul 7;3:100089. doi: 10.1016/j.ijpx.2021.100089. eCollection 2021 Dec. Int J Pharm X. 2021. PMID: 34977557 Free PMC article.
-
The "specific" P-glycoprotein inhibitor zosuquidar (LY335979) also weakly inhibits human organic cation transporters.Naunyn Schmiedebergs Arch Pharmacol. 2025 Jun;398(6):7147-7153. doi: 10.1007/s00210-024-03743-y. Epub 2024 Dec 24. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 39718614 Free PMC article.
-
In Vitro Models of the Blood-Brain Barrier.Handb Exp Pharmacol. 2021;265:75-110. doi: 10.1007/164_2020_370. Handb Exp Pharmacol. 2021. PMID: 32562060
-
The putative proton-coupled organic cation antiporter is involved in uptake of triptans into human brain capillary endothelial cells.Fluids Barriers CNS. 2024 May 6;21(1):39. doi: 10.1186/s12987-024-00544-6. Fluids Barriers CNS. 2024. PMID: 38711118 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous